EP Patent

EP3906928A1 — Treatment of pulmonary complications of coronavirus

Assigned to Noorik Biopharmaceuticals AG · Expires 2021-11-10 · 5y expired

What this patent protects

Methods and formulations are provided for the treatment and prevention of the pulmonary complications of coronavirus infections.

USPTO Abstract

Methods and formulations are provided for the treatment and prevention of the pulmonary complications of coronavirus infections.

Drugs covered by this patent

Patent Metadata

Patent number
EP3906928A1
Jurisdiction
EP
Classification
—
Expires
2021-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Noorik Biopharmaceuticals AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.